1. Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR‐SOB Scores From ADNI. (2nd October 2013) Authors: Delor, I; Charoin, J‐E; Gieschke, R; Retout, S; Jacqmin, P Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 10(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P805 Selnoflast, a potent NLRP3 inhibitor - results from a phase 1b experimental medicine study in patients with Ulcerative Colitis. (30th January 2023) Authors: Klughammer, B; Piali, L; Nica, A C; Nagel, S; Bailey, L; Jochum, C; Ignatenko, S; Bläuer, A; Danilin, S; Gulati, P; Hayward, J; Scepanovic, P; Retout, S; Zhang, J D; Bhosale, S; Sue-Ling, K; Chong, C F; Christ, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P89 Emicizumab development in paediatric patients with congenital hemophilia A and inhibitors against factor VIII. Issue 6 (17th May 2019) Authors: Schmitt, C; Yoneyama, K; Chang, T; Retout, S; Grimm, H -P; Levy, GG Journal: Archives of disease in childhood Issue: Volume 104:Issue 6(2019) Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics. (9th April 2014) Authors: Combes, FP; Retout, S; Frey, N; Mentré, F Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 4(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗